Orthogon Therapeutics
About Orthogon Therapeutics
Orthogon Therapeutics is a Therapeutics startup based in Canton, MA, USA that has raised $29M in venture capital across 4 funding rounds since 2016. The company reached Series A stage in March 2018 with a $4.4M round led by institutional investors. Orthogon Therapeutics's investor base includes 1 institutional fund, with its lead investor leading the most recent equity round.
Orthogon Therapeutics is a polyomavirus-focused biopharmaceutical company developing first-in-class oral antiviral therapies for BK virus infections, a leading cause of graft loss and complications in transplant patients with no currently approved treatments. Using structure-based drug design and machine learning, the company's lead asset uniquely targets both the viral capsid protein VP1 and large T antigen LTAg, enabling potent antiviral activity at the site of viral replication.
Orthogon Therapeutics Funding Rounds Timeline
4 rounds · $29M raised · since 2016
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series A | March 2018 | $4.4M | — | — | — |
| Follow-On | November 2021 | $8M | — | — | Over-the-Rhine Ventures, Holbrook Angels, Healthcare Angels |
| Follow-On | December 2024 | $5.2M | — | — | — |
| Follow-On | April 2026 | $11M | — | — | Massinvestor |
Investors in Orthogon Therapeutics
1 institutional investors across 4 rounds
Co-investors
Recent news about Orthogon Therapeutics
- FundingOrthogon Therapeutics Pulls in $11M FundingApril 2026
Questions about Orthogon Therapeutics
How much has Orthogon Therapeutics raised?
Orthogon Therapeutics has raised $29M across 4 funding rounds since 2016.
Who are the investors of Orthogon Therapeutics?
Orthogon Therapeutics's investors include Massinvestor.
When was Orthogon Therapeutics's last funding round?
Orthogon Therapeutics's most recent round was a $4.4M Series A in March 2018.
Where is Orthogon Therapeutics headquartered?
Orthogon Therapeutics is headquartered in Canton, MA, USA, and was founded in 2016 by Ali H. Munawar.